NEW YORK, Sept. 10 (GenomeWeb News) - Bjorn Bontin has been appointed chief financial officer and manager of investor relations at Gyros, of Uppsala, Sweden, the company said today.
Bontin comes to the company, which makes microfluidics devices on a compact disk formats for genomics and proteomics applications, from IBS (International Business Systems) where he was CFO and investor relations manager.
He replaces Mathias Brandhammar, formerly the company's vice president for finance and administration, who is now administration officer.
Human genome sequencing leaders Francis Collins and Aristedes Patrinos are being honored with awards from the US Department of Energy today.
The awards ceremony was scheduled to take place late this morning at the DOE headquarters in Washington, DC, and to be presided over by Spencer Abraham, the Secretary of Energy, along with Elias Zerhouni, director of the NIH.
Collins is the director of the National Human Genome Research Institute, and Patrinos leads the DOE's Office of Biological and Environmental Research at its Office of Science. They are being honored with the DOE's highest award for the completion of the human genome project in April of this year, over two years ahead of schedule.
Michael Knable has been appointed to the board of directors of Psychiatric Genomics, the firm said today in announcing an additional $6 million in financing.
Knable is executive director of Stanley Medical Research Institute, which provided this latest round of financing, and also serves on Psychiatric Genomics' scientific advisory board. He was previously deputy medical director of the National Institute of Mental Health's neuropsychiatric research at St. Elizabeth's hospital in Washington, DC.
Rajiv Doshi has joined De Novo Ventures, a Menlo Park, Calif., early-stage life sciences venture capital firm, as a principal, the company said Sep. 9.
Doshi is currently a lecturer at Stanford University's Department of Medicine, where he has taught courses in design of medical devices. He was previously consulting with medical device companies in the gastroenterology, pulmonology, and cardiology areas, and is on the medical advisory board of Lunar Design, which performs industrial design and engineering. He also has five patents either issued or pending for medical devices he created.
Thomas Goralski has been appointed the laboratory director of Expression Analysis, the Durham, NC-based microarray service firm said Sept. 8.
Goralski comes to Expression Analysis from Perlegen Sciences, where he was manager of the high-throughput laboratory for SNP identification. Prior to joining Perlegen, Goralski worked at Incyte Genomics, in the sequencing and microarray areas.
Goralski is the 14th employee at Expression Analysis.
Mary Jane Cunningham has been appointed Associate Director of Life Sciences & Health at the Houston Advanced Research Center, a non-profit organization designed to apply principles of sustainable development in Texas, the center said Sept. 5.
Cunningham comes to HARC from Molecular Mining, of Kingston, Ontario, where she was director of discoveries. Before her stint at Molecular Mining, was director of pharmacogenomics at now-defunct microarray firm GenoMetrix, of The Woodlands, Texas.
Perry Karsen has been named senior vice president of business development at Human Genome Sciences, the Rockville, Md., company said Sept. 4.
Karsen was previously a general partner at New York-based Pequot Ventures, where he was responsible for biotechnology and medical devices investment. Prior to that, Karsen served in marketing and business development positions at Bristol-Myers Squibb from 1995 to 2000, and at Genentech, as director of business development and representative director, Japan, before that. He also worked in numerous management roles at Abbott Laboratories from 1983 to 1994.